Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma

Japanese Journal of Clinical Oncology

Volumn 42, Issue 3, 2012, Pages 196-201

  He, Shiming ^a   Deng, Jianping ^a   Li, Gang ^a   Wang, Boliang ^a   Cao, Yizhan ^a   Tu, Yanyang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Expression; Glioma; Immunohistochemistry; Neural precursor cell expressed developmentally down regulated 4 like; Western blot analysis

Indexed keywords

NEDD4L PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CHILD; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; NONPARAMETRIC TEST; OVERALL SURVIVAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; SCHOOL CHILD; TUMOR NECROSIS; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; BRAIN NEOPLASMS; CHILD; DOWN-REGULATION; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN-PROTEIN LIGASES; YOUNG ADULT;

EID: 84863250974     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyr195     Document Type: Article

References (19)

1. Louis DN, Ohgaki H, Wiestler OD. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114: 97-109.
2. Shankavaram UT, Bredel M, Burgan WE, Carter D, Tofilon P, Camphausen K. Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma. J Cell Mol Med 2011 (in press). doi:10.1111/j.1582-4934.2011.01345.x.
3. Liu X, Tang H, Zhang Z, Li W, Wang Z, Zheng Y, et al. POTEH hypomethylation, a new epigenetic biomarker for glioma prognosis. Brain Res 2011;1391:125-31.
4. Kimura T, Kawabe H, Jiang C, Zhang W, Xiang YY, Lu C, et al. Deletion of the ubiquitin ligase Nedd4L in lung epithelia causes cystic fibrosis-like disease. Proc Natl Acad Sci USA 2011;108:3216-21.
5. Zheng X, Morrison AC, Feingold E, Turner ST, Ferrell RE. Association between NEDD4L gene and sodium lithium countertransport. Am J Hypertens 2011;24:145-8.
6. Jin HS, Hong KW, Lim JE, Hwang SY, Lee SH, Shin C, et al. Genetic variations in the sodium balance-regulating genes ENaC, NEDD4L, NDFIP2 and USP2 influence blood pressure and hypertension. Kidney Blood Press Res 2010;33:15-23.
7. Takeuchi T, Adachi Y, Nagayama T, Furihata M. Nedd4L modulates the transcription of metalloproteinase-1 and -13 genes to increase the invasive activity of gallbladder cancer. Int J Exp Pathol 2011;92: 79-86.
8. Javelaud D, Alexaki VI, Dennler S, Mohammad KS, Guise TA, Mauviel A. TGF-fbetag/SMAD/GLI2 signaling axis in cancer progression and metastasis. Cancer Res 2011;71:5606-10.
9. Strelau J, Schmeer C, Peterziel H, Sackmann T, Herold-Mende C, Steiner H, et al. Expression and putative functions of GDF-15, a member of the TGF-beta superfamily, in human glioma and glioblastoma cell lines. Cancer Lett 2008;270:30-9.
10. Garrone NF, Blazer-Yost BL, Weiss RB, Lalouel JM, Rohrwasser A. A human polymorphism affects NEDD4L subcellular targeting by leading to two isoforms that contain or lack a C2 domain. BMC Cell Biol 2009;10:26.
11. Araki N, Umemura M, Miyagi Y, Yabana M, Miki Y, Tamura K, et al. Expression, transcription, and possible antagonistic interaction of the human Nedd4L gene variant: implications for essential hypertension. Hypertension 2008;51:773-7.
12. Gao S, Alarcón C, Sapkota G, Rahman S, Chen PY, Goerner N, et al. Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. Mol Cell 2009;36:457-68.
13. Zhang H, Meng F, Wu S, Kreike B, Sethi S, Chen W, et al. Engagement of I-branching fbetag-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-fbetag signaling. Cancer Res 2011;71:4846-56.
14. Wang SE. The functional crosstalk between HER2 tyrosine kinase and TGF-β signaling in breast cancer malignancy. J Signal Transduct 2011;2011:804236.
15. Band AM, Laiho M. Crosstalk of TGF-β and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 2011;16:109-15.
16. Meulmeester E, Ten Dijke P. The dynamic roles of TGF-β in cancer. J Pathol 2011;223:205-18.
17. Tritschler I, Gramatzki D, Capper D, Mittelbronn M, Meyermann R, Saharinen J, et al. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells. Int J Cancer 2009;125:530-40.
18. Peñuelas S, Anido J, Prieto-Sánchez RM, Folch G, Barba I, Cuartas I, et al. TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 2009;15:315-27.
19. Lu Y, Jiang F, Zheng X, Katakowski M, Buller B, To SS, et al. TGF-β1 promotes motility and invasiveness of glioma cells through activation of ADAM17. Oncol Rep 2011;25:1329-35.